For: | Rhim H, Lim HK, Choi D. Current status of radiofrequency ablation of hepatocellular carcinoma. World J Gastrointest Surg 2010; 2(4): 128-136 [PMID: 21160861 DOI: 10.4240/wjgs.v2.i4.128] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v2/i4/128.htm |
Number | Citing Articles |
1 |
Stephan Clasen, Philippe L. Pereira, Andreas Lubienski, Arnd-Oliver Schäfer, Andreas H. Mahnken, Thomas Helmberger, Martin G. Mack, Katrin Eichler, Thomas J. Vogl, Christian Rosenberg, Suzanne C. Schiffman, Robert C. G. Martin, Thierry de Baère, Philipp Bruners, Markus Düx, Konrad Mohnike, Jens Ricke, Philip Ditter, Kai E. Wilhelm, Holger Strunk, Alexander Beck, Susanne Hengst, Joseph P. Erinjeri, Thomas Gast. CT- and MR-Guided Interventions in Radiology. 2013; : 205 doi: 10.1007/978-3-642-33581-5_13
|
2 |
Nadia F. El Ameen, Hosny S. Abdel Ghany, Mostafa M. Elian, Tamer El Zaeem. MDCT assessment of HCC patient after radiofrequency ablation among Egyptian population: Preliminary experience. The Egyptian Journal of Radiology and Nuclear Medicine 2014; 45(2): 409 doi: 10.1016/j.ejrnm.2014.02.003
|
3 |
In Young Choi, Pyo Nyun Kim, Sung Gu Lee, Hyung Jin Won, Yong Moon Shin. Efficacy and Safety of Radiofrequency Ablation for Focal Hepatic Lesions Adjacent to Gallbladder: Reconfiguration of the Ablation Zone through Probe Relocation and Ablation Time Reduction. Journal of Vascular and Interventional Radiology 2017; 28(10): 1395 doi: 10.1016/j.jvir.2017.06.004
|
4 |
Ahmed Kaml El dorry, Mohammed Kamal Shaker, Nevien Fouad EL-Fouly, Ahmed Hussien, Runia Fouad El-Folly, Amr Hafez El Fouly, Karim Abd El Tawab. Effectiveness of combined therapy radiofrequency ablation/transarterial chemoembolization versus transarterial chemoembolization/radiofrequency ablation on management of hepatocellular carcinoma. European Journal of Gastroenterology & Hepatology 2021; 33(12): 1573 doi: 10.1097/MEG.0000000000001878
|
5 |
David A. Bush, Michael Volk, Jason C. Smith, Mark E. Reeves, Samrat Sanghvi, Jerry D. Slater, Michael deVera. Proton beam radiotherapy versus transarterial chemoembolization for hepatocellular carcinoma: Results of a randomized clinical trial. Cancer 2023; 129(22): 3554 doi: 10.1002/cncr.34965
|
6 |
John Wong, Kit‐Fai Lee, Simon Chun‐Ho Yu, Paul Sing‐Fun Lee, Yue‐Sun Cheung, Ching‐Ning Chong, Philip Ching‐Tak Ip, Paul Bo‐San Lai. Percutaneous radiofrequency ablation versus surgical radiofrequency ablation for malignant liver tumours: the long‐term results. HPB 2013; 15(8): 595 doi: 10.1111/hpb.12014
|
7 |
Ronnie TP Poon, Nicholas Borys. Lyso-Thermosensitive Liposomal Doxorubicin: An Adjuvant to Increase The Cure Rate of Radiofrequency Ablation in Liver Cancer. Future Oncology 2011; 7(8): 937 doi: 10.2217/fon.11.73
|
8 |
Tienshin Chou, Cho-Li Yen, Li-Wei Chen, Cheng-Hung Chien. One-Step Method in Creation of Artificial Ascites. Journal of Medical Ultrasound 2022; 30(4): 287 doi: 10.4103/jmu.jmu_17_22
|
9 |
Shaikh Afaq, Jayesh M. Soni, Anil K. Pillai. Liver Diseases. 2020; : 687 doi: 10.1007/978-3-030-24432-3_63
|
10 |
Panadda Rojpibulstit, Suthathip Kittisenachai, Songchan Puthong, Sirikul Manochantr, Pornpen Gamnarai, Sarawut Jitrapakdee, Sittiruk Roytrakul. Hep88 mAb-initiated paraptosis-like PCD pathway in hepatocellular carcinoma cell line through the binding of mortalin (HSPA9) and alpha-enolase. Cancer Cell International 2014; 14(1) doi: 10.1186/s12935-014-0069-9
|
11 |
Toru Ishikawa, Michitaka Imai, Masayoshi Ko, Hiroki Sato, Yujiro Nozawa, Tomoe Sano, Akito Iwanaga, Keiichi Seki, Terasu Honma, Toshiaki Yoshida. Effect of treatment support on preventing local recurrence of hepatocellular carcinoma directly adjacent to the diaphragm. Molecular and Clinical Oncology 2017; 7(1): 61 doi: 10.3892/mco.2017.1257
|
12 |
Qian Feng, Yugang Chi, Yanqian Liu, Ling Zhang, Qi Liu. Efficacy and safety of percutaneous radiofrequency ablation versus surgical resection for small hepatocellular carcinoma: a meta-analysis of 23 studies. Journal of Cancer Research and Clinical Oncology 2015; 141(1): 1 doi: 10.1007/s00432-014-1708-1
|
13 |
Xue-feng Kan, Yong Wang, Guo-cheng Lin, Xiang-wen Xia, Bin Xiong, Guo-feng Zhou, Hui-min Liang, Gan-sheng Feng, Chuan-sheng Zheng. Radiofrequency ablation combined with transarterial chemoembolization for liver metastases from gastrointestinal cancers. Journal of Huazhong University of Science and Technology [Medical Sciences] 2016; 36(2): 200 doi: 10.1007/s11596-016-1566-y
|
14 |
Xuxiao Chen, Yongjun Chen, Qinyu Li, Di Ma, Baiyong Shen, Chenghong Peng. Radiofrequency ablation versus surgical resection for intrahepatic hepatocellular carcinoma recurrence: a meta-analysis. Journal of Surgical Research 2015; 195(1): 166 doi: 10.1016/j.jss.2015.01.042
|
15 |
Jennifer Guy, Robin K. Kelley, John Roberts, Robert Kerlan, Francis Yao, Norah Terrault. Multidisciplinary Management of Hepatocellular Carcinoma. Clinical Gastroenterology and Hepatology 2012; 10(4): 354 doi: 10.1016/j.cgh.2011.11.008
|
16 |
Constantinos T. Sofocleous, Sandeep Garg, Lydia M. Petrovic, Mithat Gonen, Elena N. Petre, David S. Klimstra, Stephen B. Solomon, Karen T. Brown, Lynn A. Brody, Ann M. Covey, Ronald P. DeMatteo, Lawrence Schwartz, Nancy E. Kemeny. Ki-67 is a Prognostic Biomarker of Survival after Radiofrequency Ablation of Liver Malignancies. Annals of Surgical Oncology 2012; 19(13): 4262 doi: 10.1245/s10434-012-2461-9
|
17 |
Wei Liu, Jian-Guo Zhou, Yi Sun, Lei Zhang, Bao-Cai Xing. Hepatic Resection Improved the Long-Term Survival of Patients with BCLC Stage B Hepatocellular Carcinoma in Asia: a Systematic Review and Meta-Analysis. Journal of Gastrointestinal Surgery 2015; 19(7): 1271 doi: 10.1007/s11605-015-2811-6
|
18 |
Jian-Hong Zhong, Bang-De Xiang, Wen-Feng Gong, Yang Ke, Qin-Guo Mo, Liang Ma, Xing Liu, Le-Qun Li, Matias A. Avila. Comparison of Long-Term Survival of Patients with BCLC Stage B Hepatocellular Carcinoma after Liver Resection or Transarterial Chemoembolization. PLoS ONE 2013; 8(7): e68193 doi: 10.1371/journal.pone.0068193
|